Drugs Made In America Acquisition Corp. Rights (DMAAR)

Drugs Made In America Acquisition Corp. Rights (DMAAR) is a company listed on the NASDAQ.

As of Oct 23, 2026: returns 1 week -16.4%, 1 year -44.3%.

DMAAR financial model: income statement, cash flow and balance sheet